This study is testing a new medication for patients who have group 1 PAH.
Thank you for your interest, but this study is recruiting by invitation only.
United States (Nationwide)
Jimmy Ford
Medicine-Pulmonary
Clinical or Medical
Interventional
Chronic Conditions
Lungs and Breathing
Rare Diseases
23-3148
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
